Astrana Health, Inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.39 USD | -0.86% | +3.32% | +8.07% |
May. 30 | Baird Starts Astrana Health With Outperform Rating, $54 Price Target | MT |
May. 16 | Transcript : Astrana Health, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.07% | 2.02B | |
+24.43% | 88.22B | |
-22.82% | 76.5B | |
+1.76% | 26.97B | |
+7.77% | 18.61B | |
-12.71% | 16.72B | |
+3.45% | 15.85B | |
+74.36% | 13.41B | |
+78.22% | 13.16B | |
+37.30% | 12.62B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024